These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24748428)

  • 1. Adverse drug reaction reporting by patients: an overview of fifty countries.
    Margraff F; Bertram D
    Drug Saf; 2014 Jun; 37(6):409-19. PubMed ID: 24748428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities' Views and Needs.
    Matos C; Härmark L; van Hunsel F
    Drug Saf; 2016 Nov; 39(11):1105-1116. PubMed ID: 27581398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse Drug Reaction Reporting by Patients in 12 European Countries.
    Valinciute-Jankauskiene A; Kubiliene L
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33562536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of online reporting systems and their compatibility check with respective adverse drug reaction reporting forms.
    Maharshi V; Nagar P
    Indian J Pharmacol; 2017; 49(5):374-382. PubMed ID: 29515278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries.
    Worakunphanich W; Youngkong S; Suwankesawong W; Anderson C; Thavorncharoensap M
    Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of patient reporting to the pharmacovigilance system: a systematic review.
    Inácio P; Cavaco A; Airaksinen M
    Br J Clin Pharmacol; 2017 Feb; 83(2):227-246. PubMed ID: 27558545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comment on: "Adverse drug reaction reporting by patients: an overview of fifty countries".
    Ahmad SR
    Drug Saf; 2015 Jan; 38(1):109-10. PubMed ID: 25414075
    [No Abstract]   [Full Text] [Related]  

  • 9. Direct reporting of adverse drug reactions by healthcare consumers in Africa: a narrative review.
    Adedeji-Adenola H; Nlooto M
    Int J Clin Pharm; 2021 Feb; 43(1):11-24. PubMed ID: 32902780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of national spontaneous reporting schemes. Strengths and weaknesses.
    Hughes ML; Whittlesea CM; Luscombe DK
    Adverse Drug React Toxicol Rev; 2002; 21(4):231-41. PubMed ID: 12503256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a New Consumer Form on the Quantity and Quality of Adverse Event Reports Submitted to the United States Food and Drug Administration.
    Muñoz MA; Delcher C; Dal Pan GJ; Kortepeter CM; Wu E; Wei YJ; Xiao H; Winterstein AG
    Pharmacotherapy; 2019 Nov; 39(11):1042-1052. PubMed ID: 31479525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Authors' reply to Ahmad SR: "Adverse drug reaction reporting by patients: an overview of fifty countries".
    Margraff F; Bertram D
    Drug Saf; 2015 Jan; 38(1):111. PubMed ID: 25414076
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi.
    Jusot V; Chimimba F; Dzabala N; Menang O; Cole J; Gardiner G; Ofori-Anyinam O; Oladehin O; Sambakunsi C; Kawaye M; Stegmann JU; Guerra Mendoza Y
    Drug Saf; 2020 Jun; 43(6):583-593. PubMed ID: 32239447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experiences with adverse drug reaction reporting by patients: an 11-country survey.
    van Hunsel F; Härmark L; Pal S; Olsson S; van Grootheest K
    Drug Saf; 2012 Jan; 35(1):45-60. PubMed ID: 22149419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
    Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
    Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reaction reporting in the Czech Republic 2005-2009.
    Kopečná E; Deščíková V; Vlček J; Mladá J
    Int J Clin Pharm; 2011 Aug; 33(4):683-9. PubMed ID: 21678040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Assessment of the National Pharmacovigilance Systems in East Africa: Ethiopia, Kenya, Rwanda and Tanzania.
    Barry A; Olsson S; Minzi O; Bienvenu E; Makonnen E; Kamuhabwa A; Oluka M; Guantai A; Bergman U; van Puijenbroek E; Gurumurthy P; Aklillu E
    Drug Saf; 2020 Apr; 43(4):339-350. PubMed ID: 31919794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals.
    McLernon DJ; Bond CM; Hannaford PC; Watson MC; Lee AJ; Hazell L; Avery A;
    Drug Saf; 2010 Sep; 33(9):775-88. PubMed ID: 20701410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with spontaneous adverse drug reaction reporting among healthcare professionals in Vietnam.
    Le TT; Nguyen TTH; Nguyen C; Tran NH; Tran LA; Nguyen TB; Nguyen N; Nguyen HA
    J Clin Pharm Ther; 2020 Feb; 45(1):122-127. PubMed ID: 31486525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoting spontaneous adverse drug reaction reporting in hospitals using a hyperlink to the online reporting form: an ecological study in Portugal.
    Ribeiro-Vaz I; Santos C; da Costa-Pereira A; Cruz-Correia R
    Drug Saf; 2012 May; 35(5):387-94. PubMed ID: 22468615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.